GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $572,000 | -72.2% | 19,444 | -58.9% | 0.01% | -74.5% |
Q2 2022 | $2,060,000 | -0.4% | 47,328 | -0.2% | 0.05% | +14.6% |
Q1 2022 | $2,069,000 | -2.0% | 47,443 | -0.9% | 0.04% | +2.5% |
Q4 2021 | $2,112,000 | +15.6% | 47,894 | +0.1% | 0.04% | +5.3% |
Q3 2021 | $1,827,000 | +108.6% | 47,848 | +117.6% | 0.04% | +81.0% |
Q2 2021 | $876,000 | +7.6% | 21,987 | -3.7% | 0.02% | 0.0% |
Q1 2021 | $814,000 | +25.8% | 22,836 | +29.9% | 0.02% | +10.5% |
Q4 2020 | $647,000 | -0.6% | 17,580 | +1.6% | 0.02% | -20.8% |
Q3 2020 | $651,000 | -8.8% | 17,303 | -1.1% | 0.02% | -14.3% |
Q2 2020 | $714,000 | -1.9% | 17,500 | -8.9% | 0.03% | -17.6% |
Q1 2020 | $728,000 | -13.2% | 19,214 | +7.6% | 0.03% | 0.0% |
Q4 2019 | $839,000 | +7.2% | 17,864 | -2.7% | 0.03% | 0.0% |
Q3 2019 | $783,000 | -12.1% | 18,355 | -17.5% | 0.03% | -12.8% |
Q2 2019 | $891,000 | +15.0% | 22,255 | +19.9% | 0.04% | +11.4% |
Q1 2019 | $775,000 | +8.4% | 18,555 | -0.9% | 0.04% | -5.4% |
Q4 2018 | $715,000 | -5.2% | 18,730 | -0.3% | 0.04% | 0.0% |
Q3 2018 | $754,000 | +1.1% | 18,785 | +1.5% | 0.04% | -5.1% |
Q2 2018 | $746,000 | -99.9% | 18,510 | -1.1% | 0.04% | -2.5% |
Q1 2018 | $731,000,000 | +10.1% | 18,710 | 0.0% | 0.04% | +11.1% |
Q4 2017 | $663,644,000 | +40.4% | 18,710 | +60.7% | 0.04% | +33.3% |
Q3 2017 | $472,746,000 | -6.6% | 11,644 | -0.8% | 0.03% | -10.0% |
Q2 2017 | $506,229,000 | +3.3% | 11,740 | +1.0% | 0.03% | 0.0% |
Q1 2017 | $490,110,000 | +14.8% | 11,625 | +4.8% | 0.03% | +7.1% |
Q4 2016 | $427,076,000 | -15.7% | 11,090 | -5.5% | 0.03% | -17.6% |
Q3 2016 | $506,347,000 | -4.5% | 11,740 | -4.1% | 0.03% | -8.1% |
Q2 2016 | $530,482,000 | -0.9% | 12,240 | -7.3% | 0.04% | -2.6% |
Q1 2016 | $535,423,000 | +1.9% | 13,204 | +1.4% | 0.04% | +2.7% |
Q4 2015 | $525,196,000 | +5.8% | 13,016 | +0.8% | 0.04% | 0.0% |
Q3 2015 | $496,621,000 | -7.7% | 12,916 | 0.0% | 0.04% | -2.6% |
Q2 2015 | $537,952,000 | -14.3% | 12,916 | -5.0% | 0.04% | -11.6% |
Q1 2015 | $627,548,000 | +10.2% | 13,598 | +2.1% | 0.04% | +7.5% |
Q4 2014 | $569,425,000 | +0.9% | 13,323 | +8.6% | 0.04% | -4.8% |
Q3 2014 | $564,190,000 | -6.6% | 12,273 | +8.6% | 0.04% | -6.7% |
Q2 2014 | $604,271,000 | +1.9% | 11,299 | +1.8% | 0.04% | -4.3% |
Q1 2014 | $593,020,000 | -4.9% | 11,099 | -5.0% | 0.05% | -6.0% |
Q4 2013 | $623,542,000 | +12.0% | 11,679 | +5.2% | 0.05% | +2.0% |
Q3 2013 | $556,836,000 | +0.4% | 11,099 | 0.0% | 0.05% | -3.9% |
Q2 2013 | $554,617,000 | – | 11,099 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |